Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: Protective effect of HDL cholesterol in women

Atherosclerosis

Volumn 128, Issue 1, 1997, Pages 113-119

  Fagot Campagna, Anne ^a   Narayan, K M Venkat ^a   Hanson, Robert L ^a   Imperatore, Giuseppina ^a   Howard, Barbara V ^b   Nelson, Robert G ^a   Pettitt, David J ^a   Knowler, William C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Medlantic Research Institute   (United States)

Author keywords

Glucose; Incidence; Insulin resistance; Lipoprotein; Sex

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; ARIZONA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TRIGLYCERIDES;

EID: 0031048517     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05978-3     Document Type: Article

References (47)

1. Reaven GM. Banting lecture: Role of insulin resistance in human diseases. Diabetes 1988;37:1595-1607.
2. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-2898.
3. Papoz L, Eschwege E, Warnet JM, Richard JL, Claude JR. Incidence and risk factors of diabetes in the Paris Prospective Study (G.R.E.A). In: E. Eschwege (ed). Advances in Diabetes Epidemiology. Amsterdam: Elsevier Biomedical Press, 1982;113-122.
4. Ohlson LO, Larsson B, Björntorp P et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988;31:798-805.
5. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990;131:443-453.
6. Balkau B, King H, Zimmet P, Raper LR. Factors associated with the development of diabetes in the Micronesian population in Nauru. Am J Epidemiol 1985;122:594-605.
7. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971;2:125-128.
8. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978;108:497-505.
9. Howard BV, Davis MP, Pettitt DJ, Knowler WC, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians. Circulation 1983;68:714-724.
10. Howard BV, Lee ET, Cowan LD et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995;142:254-268.
11. National Center for Health Statistics, Carroll M, Sempos C, Briefel R, Johnson C. Serum lipids of adults 20-74 years: United States, 1976-80. Vital and Health Statistics, Series 11, No. 242, DHHS Public Health Service Publication No (PHS) 93-1692. Washington, DC: US Government Printing Office, 1993.
12. World Health Organization Study Group on Diabetes Mellitus. Diabetes Mellitus. WHO Technical Reports. Geneva: World Health Organization, 1985;127.
13. Herbert VJ, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1995;25:1375-1384.
14. Rush RL, Leon L, Turrell J. Automated simultaneous cholesterol and triglyceride determination on the auto analyzer instrument. In: Advances in Automated Analyses. Miami, FL: Thurman, 1970;503.
15. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-482.
16. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-220.
17. Breslow NE, Day NE. Unconditional logistic regression for large strata. In: Statistical Methods in Cancer Research, Vol I - The Analysis of Case-Control Studies, IARC Publication No 32. Lyon: International Agency for Research on Cancer, 1980;191-259.
18. Kalbfleisch JD, Prentice RL. Likelihood construction and further results on the proportional hazards model. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, 1980;119-142.
19. Sluiter WJ, Erkelens DW, Terpstra P, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 1976;25:245-249.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
21. Anderson RL, Hamman RF, Savage PJ et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 1995;142:724-732.
22. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. I. Assay of the beta-cell response after oral glucose loading. Diabetes 1976;25:241-244.
23. Rothman KJ, Boice JC. Follow-up (cohort) studies. In: Epidemiologic Analysis with a Programmable Calculator, NIH Publication 79-1649. Washington, DC: National Institutes of Health, 1979;11-17.
24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
25. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
26. Reaven GM. Lipid disorders in patients with NIDDM. IDF Bulletin, Symp XXXV, 1995;11-14.
27. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin-dependent diabetes in middle aged British men. Br Med J 1995;310:560-564.
28. Wilson PW, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly: the Framingham Study. Am J Med 1986;80(Suppl 5A):3-9.
29. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years. The Framingham Study. Am J Epidemiol 1981;114:697-704.
30. Jarrett RJ, Keen H, McCartney P. Worsening to diabetes in persons with impaired glucose tolerance: ten year experience in the Bedford and Whitehall studies. Advances in Diabetes Epidemiology, INSERM Symp, 1982;22:95-102
31. Burchfiel CM, Sharp DS, Curb JD et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol 1995;141:360-368.
32. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993;36:553-559.
33. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
34. Merrin PK, Baynes C, Henderson A, Richmond B, Elkeles R. The effects of gender and type of diabetes on HDL cholesterol. Diabete Metab 1994;20:20-24.
35. Laakso M. How good is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-965.
36. Medalie JH, Papier C, Herman JB et al. Diabetes mellitus among 10000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci 1974;10:681-697.
37. Stern MP, Morales PA, Valdes RA et al. Predicting diabetes. Moving beyond impaired glucose tolerance. Diabetes 1993;42:706-714.
38. Tataranni PA, Baier LJ, Paolisso G, Howard BV, Ravussin E. Role of lipids in development of noninsulin-dependent diabetes mellitus: lessons learned from Pima Indians. Lipids 1996;31(Suppl):S265-S270.
39. Warne DK, Charles MA, Hanson RL et al. Comparaison of body size measurements as predictors of NIDDM in Pima Indians. Diabetes Care 1995;18(4):435-439.
40. Castelli WP, Gordon T, Hortland MC et al. Alcohol and blood lipids: The Cooperative Lipoprotein Phenotyping Study. Lancet, July 1977;23:153-155.
41. Holbrook TL, Barrett-Connor E, Wingard DL. A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132:902-909.
42. Stampfer MJ, Colditz GA, Willett WA et al. A prospective study of moderate alcohol drinking and risk of diabetes in women. Am J Epidemiol 1988;128:549-558.
43. Miller VT. Lipids, lipoproteins, women and cardiovascular disease. Atherosclerosis 1994;108(Suppl):S73-S82.
44. Haffner SM, Valdez RA. Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am J med 1995;98(Suppl 1A):40S-47S.
45. Pugeat M, Moulin P, Cousin P et al. Interrelations between sex-hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J Steroid Biochem Mol Biol 1995;53:567-572.
46. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone binding globulin predicts non-insulin dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:56-60.
47. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Björntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-year follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991;40:123-128.